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Background: The metabolic network of H. sapiens and many other organisms is described in multiple pathway
databases. The level of agreement between these descriptions, however, has proven to be low. We can use these
different descriptions to our advantage by identifying conflicting information and combining their knowledge into
a single, more accurate, and more complete description. This task is, however, far from trivial.
Results: We introduce the concept of Consensus and Conflict Cards (C2Cards) to provide concise overviews of
what the databases do or do not agree on. Each card is centered at a single gene, EC number or reaction. These
three complementary perspectives make it possible to distinguish disagreements on the underlying biology of a
metabolic process from differences that can be explained by different decisions on how and in what detail to
represent knowledge. As a proof-of-concept, we implemented C2Cards
Human, as a web application
http://www.molgenis.org/c2cards, covering five human pathway databases.
Conclusions: C2Cards can contribute to ongoing reconciliation efforts by simplifying the identification of consensus
and conflicts between pathway databases and lowering the threshold for experts to contribute. Several case studies
illustrate the potential of the C2Cards in identifying disagreements on the underlying biology of a metabolic
process. The overviews may also point out controversial biological knowledge that should be subject of further
research. Finally, the examples provided emphasize the importance of manual curation and the need for a broad
community involvement.
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Metabolic pathway databases have proven very valuable
for a wide range of applications, varying from the analysis
of high-throughput data to in silico phenotype prediction.
In the past decade the number of pathway databases has
grown markedly, providing extensive descriptions of the
metabolic network for an increasing number of organisms
[1,2]. The metabolic networks of several key organisms, for
example, S. cerevisiae and H. sapiens, are even described in
multiple databases. A comparison of two yeast networks
showed, however, that the two agreed on only 36% of their
reactions [3]. Similarly, five pathway databases describing* Correspondence: p.d.moerland@amc.uva.nl
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reproduction in any medium, provided the orthe human metabolic network agreed on only 3% of the
6968 reactions they jointly contain [4]. Given that these da-
tabases aim to represent the metabolic capabilities of the
same organism, the level of agreement is much lower than
one might expect and hope for. There are several explana-
tions for the observed lack of consensus. These include the
different ways in which the networks have been built, their
manner of curation, and a different interpretation of litera-
ture [5]. The comparison of Stobbe et al. [4] also revealed
large differences in the breadth and depth of the coverage
the five human metabolic networks have.
The advantage of having several descriptions of the
metabolic network for the same organism is that they
offer different views on the same biological system and
thus can reveal controversial biological knowledge. In
addition, the databases each have a particular focus and
its curators have specific fields of expertise. Therefore,
each database may provide complementary pieces of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vations have motivated, still ongoing, efforts to consoli-
date the different networks for the same organism and
to build consensus metabolic networks using a largely
manual approach [3,6,7].
Combining all the knowledge on the metabolic network
contained in the various pathway databases and identify-
ing conflicting information is, however, far from trivial.
Retrieving all required information from multiple data-
bases is in itself already a cumbersome task. One reason
that makes it challenging to identify instances where path-
way databases do not agree on the underlying biology of a
metabolic process are the different decisions made by each
of the databases on how to represent knowledge [4,8]. For
example, a particular difference may be simply explained
by the different levels of granularity with which metabolic
processes are described by each database, instead of a fun-
damentally different biological insight. Secondly, it re-
mains a challenge to determine whether databases refer to
the same gene or the same metabolite. Thirdly, the defin-
ition of a pathway also differs per database, which makes
it nearly impossible to compare the networks on a smaller
scale, i.e., per pathway. Fourthly, the larger the number of
pathway databases considered, the more difficult it is to
identify the consensus and the conflicts. Recently, algo-
rithms have been proposed to semi-automatically merge
two descriptions of the metabolic network of the same or-
ganism [9,10]. These approaches mainly address the chal-
lenge of matching metabolites, partly via interactions with
the user. The core of their resulting merged description
consists of reactions that can be found in both networks.
Integrating more than two descriptions will, however, sig-
nificantly reduce the size of the core and limit its utility
[4]. The merged description also contains reactions that
could not be (exactly) matched and are therefore unique
to one of the descriptions. Such an approach will, how-
ever, neither resolve the conflicting information between
databases nor filter out erroneous information. Further-
more, the semi-automatic approaches do not explicitly ad-
dress all issues mentioned above. For example, conflicts
due to differences in granularity are not taken into ac-
count. While semi-automatic approaches generate a useful
scaffold for a consensus network, the resulting description
still requires extensive manual curation.
Altogether, the issues described above make the con-
struction of a single, more accurate, and more complete
network based on the pathway databases available a la-
borious and largely manual process [6]. Moreover, it is
an ongoing process, as new knowledge continues to be-
come available both in the scientific literature and in
pathway databases.
To more easily visualize the opinion of multiple path-
way databases, we introduce the concept of Consensus
and Conflict Cards (C2Cards). C2Cards combine theknowledge from multiple pathway databases for a specific
target organism. A C2Card can be centered at a single
gene, Enzyme Commission (EC) number or reaction of
interest and gives a concise overview of what the data-
bases do or do not agree on with respect to the entity the
C2Card is centered at. These three perspectives offer
complementary views on the knowledge contained in the
pathway databases. Importantly, using these perspectives
disagreements caused by a different decision on how and
in how much detail to represent knowledge can be identi-
fied. C2Cards can be used to assist reconciliation efforts
and make users of pathway databases more aware of the
exact differences that currently exist between databases.
As a proof-of-concept, we implemented C2Cards
Human
(http://www.molgenis.org/c2cards), which combines the
knowledge of the following five frequently used human
pathway databases: the Biochemically, Genetically and
Genomically structured (BiGG) knowledgebase [11] (H.
sapiens Recon 1 [12]), the Edinburgh Human Metabolic
Network (EHMN) [13], HumanCyc [14], and the meta-
bolic subsets of the Kyoto Encyclopedia of Genes and
Genomes database (KEGG) [15] and Reactome [16].
Below, we first give an overview of the various features
of the C2Cards, the combined strength of the three per-
spectives, and how C2Cards can aid in the curation of
gene and metabolite identifiers. Next, we describe sev-
eral case studies illustrating the potential of the C2Cards
in identifying conflicts between pathway databases. Fi-
nally, we discuss the next steps to be taken in curating
metabolic networks.
Results
Each C2Card provides an overview of the knowledge of
multiple pathway databases from the perspective of a spe-
cific gene, EC number or reaction of interest. A C2Card
answers the basic question of which databases contain the
entity of interest. Importantly, each card provides a con-
cise overview of what the databases do and do not agree
on with respect to the entity of interest. The core compo-
nent of a C2Card is a table in which each row contains the
following basic elements: a reaction and the EC number
(s), gene(s) and pathway linked to it in one of the pathway
databases (Figure 1). If the information is available, com-
plexes and isozymes are indicated by means of Boolean
operators (see Materials and methods). Any of the afore-
mentioned elements may be missing, except for the entity
on which the C2Card is centered. By focusing on these
basic elements, the overviews remain compact. For add-
itional information provided by the pathway databases, e.g.,
pathway visualization and literature references, a direct
link is provided to the original entry of the reaction in
the pathway database. The second core component of a
C2Card is that each card explicitly indicates the similarity
of the reactions displayed on it. Similarity is indicated
Figure 1 Examples of two C2Cards. C2Card centered at the CTPS gene (top) and the C2Card retrieved by clicking on the reaction of Reactome
in the C2Card centered at the CTPS gene (bottom). Each C2Card consists of a table in which each row contains the following basic elements: a
reaction and the EC number(s), gene(s) and pathway linked to it in one of the pathway databases. One can switch perspective by clicking on any
of the elements in the table. For additional information provided by the pathway databases, e.g., pathway visualizations and literature references,
a direct link is provided to the original entry of the reaction in the pathway database. The second core ingredient of a C2Card is that each card
explicitly shows the similarity of the reactions displayed on it. The percentage of overlap between reactions is indicated and relevant cells are
colored according to the degree of overlap. Information on the IDs assigned to the metabolites and genes by a pathway database is shown by
clicking on the i icon. For EC numbers the reaction and name linked to it by NC-IUBMB are shown.
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perspective; Figure 1) or with respect to the reaction of
interest (reaction perspective; Figure 1). Here, reaction
similarity is defined as the percentage of metabolites
found in both reactions (see Materials and methods). The
strengths of each of the three perspectives are discussed in
more detail below.
Three complementary perspectives
C2Cards offer three complementary perspectives (gene,
EC number, reaction) on the knowledge contained in the
pathway databases. Each perspective can answer various
types of questions, accommodating the different inter-
ests one may have. Importantly, the three perspectives
can be used to identify and complement information
missing in one (or more) of the pathway databases using
the knowledge from the other pathway databases.
Gene perspective
The ’gene perspective’ shows for each of the pathway da-
tabases, which metabolic functions the product of a gene
has, as indicated by the reaction(s) and EC number(s)
linked to it. This perspective may also answer the ques-
tion whether other genes, either encoding isozymes or
components of the same complex, are linked to the
same reaction.
EC number perspective
The ’EC number perspective’ shows on which elements
linked to the EC number the pathway databases (dis)
agree for a specific type of conversion. It may also reveal
possible alternative substrates, which is one of the
sources of conflict between metabolic pathway databases
[4]. The C2Card centered at the EC number 1.1.1.35 (3-
hydroxyacyl-CoA dehydrogenase) provides an example
of this scenario (Additional file 1). For example, EHMN
has 62 unique reactions linked to this EC number while
both HumanCyc and Recon 1 only have two unique re-
actions. The EC number perspective can also be used toFigure 2 Excerpt of the C2Card centered at the reaction ‘ATP + UMP <
and gene, which illustrates the difference in enzyme activity assigned to th
color.answer the question which genes encode for an enzyme
with the specified enzymatic function, according to each
database.
Reaction perspective
The ‘reaction perspective’ provides a compact overview
of which gene(s) and EC number(s) are linked to a reac-
tion of interest in each pathway database. This perspec-
tive can assist in resolving a commonly occurring gap in
reconstructions of the metabolic network, namely cases
in which the gene product catalyzing a known metabolic
reaction is missing [17]. The reaction perspective (and
also the EC number perspective) can be used to find
possible candidates for a missing gene in a particular
database or reveal that the gene is missing in all pathway
databases.
By clicking on any of the entities shown in a C2Card
one can easily switch perspective. Furthermore, each
C2Card is opened in a new window to enable a simultan-
eous view of the C2Cards of a linked triple of a reaction,
EC number, and gene from different viewpoints. Using all
three perspectives is essential to get a complete picture of
what the databases do or do not agree on. The EC number
perspective can, for example, neither fully replace the gene
perspective nor the reaction perspective, as illustrated by
the example in Figure 2. An EC number does not uniquely
identify a reaction or an enzyme. As the example shows,
the pathway databases linked different EC numbers to the
same reaction. Furthermore, in this case the databases ei-
ther do not agree on the substrate specificity of the gene
product, or curators assigned the EC number based on
the reaction instead of the functionality of the gene prod-
uct (Table 1). Finally, in the C2Cards application one can
also cast a wider net when querying for an EC number by
allowing a mismatch on the fourth number of an EC
number. In contrast to the first three numbers, the last
number does not indicate a specific subclass of enzymes
and only serves to distinguish enzymes with different
substrate specificities.==> ADP + UDP’. Different EC numbers linked to the same reaction
e product of the CMPK1 gene. Matching EC numbers have the same
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Combining different perspectives also offers a way to
side-step differences that do not reflect a true disagree-
ment on the underlying biology such as the difference in
the level of detail with which a metabolite or a conver-
sion is described. Since such a difference will generally
not affect the gene or EC number that is assigned to a
reaction, these differences can be revealed using the
gene or EC number perspective. One example is that
some databases may provide the specific form of a me-
tabolite, e.g., α-D-glucose or β-D-glucose, while in other
databases the more general form is used, D-glucose in
this case. A possible motivation for database curators to
choose the general version is that in an experiment the
distinction between two isomers may be difficult to
make. A second example is that one database may choose
to describe a biochemical conversion in a single reaction
using generic metabolites, like ‘a long chain alcohol’, versus
multiple reactions with more specific examples of metabo-
lites, i.e., ‘hexadecanol’ and ‘octadecanol’ instead of ‘a long
chain alcohol’, in another database. The gene or EC num-
ber perspective can be used to uncover such a difference.
A third example is that the number of steps used to de-
scribe a biochemical process may differ, which will prevent
a perfect match on reaction level as well. Note, however,
that this difference in level of detail may not always be a
conceptual difference, but could also be due to a disagree-
ment on the underlying biology. This commonly occur-
ring difference in the number of intermediate steps can be
revealed via the gene or EC number perspective as well
(Figure 3).Gene and metabolite identity
Next to exploring the genes, EC numbers, and reactions
contained in the pathway databases, as described above,
C2Cards can also be of direct use in curating the identi-
fiers (IDs) assigned to the genes and metabolites by the
pathway databases. Identifiers are essential for the un-
ambiguous identification of genes and metabolites acrossTable 1 Definition of EC numbers in NC-IUBMB
EC number Enzyme name Reaction as defined by
NC-IUBMB
2.7.4.4 Nucleoside-phosphate
kinase
ATP + nucleoside phosphate =
ADP + nucleoside diphosphate
2.7.4.14 UMP/CMP kinase (1) ATP + (d)CMP = ADP + (d)CDP
(2) ATP + UMP = ADP + UDP
2.7.4.22 UMP kinase ATP + UMP = ADP + UDP
The enzyme name and reaction(s) linked to the EC numbers of Figure 2 by the
Nomenclature Committee of the International Union of Biochemistry and
Molecular Biology (NC-IUBMB). The information of NC-IUBMB is available in a
C2Card for each EC number that is part of the overview (see Figure 1). Note
that the EC number 2.7.4.22 is unlikely to be correct in this case as NC-IUBMB
indicates that this particular enzyme is the prokaryotic variant of the enzyme
linked to EC number 2.7.4.4.multiple resources and enable linking experimental data
to the metabolic network. For each gene and metabolite
a C2Card provides the identifiers assigned to them by
the pathway databases (see Figure 1, and Materials and
methods). Obsolete or transferred identifiers are explicitly
indicated. For genes the HUGO Gene Nomenclature
Committee (HGNC) symbol is provided and for metabo-
lites their name and synonyms. If available in a pathway
database, two structural IDs (InChI and SMILES) and the
chemical formula are also shown for a metabolite. The in-
formation on the identifiers helps to reveal cases where
the assignment of identifiers to a metabolite or gene can
be improved. Firstly, it can uncover metabolites that
completely lack an ID in one or more pathway data-
bases. Secondly, ID information can also help to identify
cases where pathway databases assigned IDs from differ-
ent gene and metabolite databases to the same entity.
This can be used to propose additional identifiers for
that particular gene or metabolite, which may also facili-
tate matching between databases. Thirdly, it can reveal
genes and metabolites to which a pathway database
assigned multiple identifiers from the same genome or
metabolite database, respectively. In summary, C2Cards
can assist the considerable amount of manual curation
required to correctly link each component of the meta-
bolic network to external databases.
The ability to correctly match metabolites when com-
paring reactions is influenced by the different decisions
the curators of the pathway databases have taken. For
example, in Recon 1 and HumanCyc the protonation
state of a metabolite is determined at a pH level of 7.2
and 7.3, respectively. The other three databases always
use the neutral form of a metabolite. As illustrated in
the C2Card centered at the CTPS gene (Figure 1), this
leads to a reaction mismatch between EHMN and
KEGG that have chosen for ammonia (NH3) and Recon
1 that has chosen ammonium. The gene and EC num-
ber perspectives offer a possible way to uncover such
differences. The C2Cards application provides an add-
itional means to uncover reactions that are similar, but
not an exact match, by allowing the user to specify that
one or more mismatches are allowed when querying for
a reaction. An example of the results of a query in
which one mismatch was allowed is given in Table 2. In
this example the reactions only differ in the level of de-
tail with which the metabolite ornithine was described.
Note also that the genes and EC number do match,
which in this case supports the notion that the two re-
actions can be considered equivalent. Allowing mis-
matches also makes it possible to retrieve reactions for
which the identity of one or more metabolites could
not be established, because of missing identifiers or for
which matching on name was hindered by the use of
different synonyms.
Figure 3 Excerpt of the C2Card centered at the EC number ‘4.2.1.3’ (aconitate hydratase). Conversion of citrate into isocitrate (part of the
TCA cycle) in one (green) or two steps (blue). The EC number and gene on which all five databases agree are underlined.
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C2Cards can be accessed using common JavaScript-enabled
browsers on all major platforms including Windows, Linux,
and Apple. A C2Card centered at a gene or EC number
of interest can be retrieved in a single step. For the
reaction perspective two routes are offered, either of
which requires three steps. A reaction can be found by
entering one or more metabolites or by selecting the
pathway it is part of in one of the pathway databases.
More detail on how to retrieve a C2Card is described on
the C2Cards website (http://www.molgenis.org/c2cards).
Once retrieved, a C2Card can also be downloaded for
off-line use. In addition, for each database the C2Cards
for all its genes, EC numbers, and reactions, respect-
ively, can be downloaded in tab-delimited format in a
single ZIP file.
Next to the web interface, programming interfaces to
R, SOAP (Simple Object Access Protocol), and REST
(Representational State Transfer) are provided to enable
programmatic querying of the collection of C2Cards.
One possible application would be to perform computa-
tional analyses on each of the pathway databases. A typ-
ical example is an enrichment test to prioritize pathwaysTable 2 Excerpt of the C2Card centered at the reaction ‘l-argi
Database Reaction Overlap (%)
H. sapiens Recon 1 l-arginine[c] + H2O[c]
→
ornithine[c] + urea[c]
100
l-arginine[m] + H2O[m]
→
ornithine[m] + urea[m]
100
Reactome l-arginine[c] + H2O[c]
→
l-ornithine[c] + urea[c]
66
l-arginine[m] + H2O[m]
→
l-ornithine[m] + urea[m]
66
One metabolite was allowed not to match in this reaction search. The only differen
bold). Note that H2O is not taken into account for computing the percentage of ovmost likely to be affected in a given high-throughput ex-
periment. The differences between pathway databases
can be quite large both with respect to content and con-
ceptual differences [4]. For example, the number of
pathways, in the five selected human pathway databases
ranges from 69 in EHMN to 257 in HumanCyc (see
Materials and methods). Consequently, it is to be
expected that the choice of a particular pathway data-
base affects the outcome of pathway enrichment ana-
lyses [18]. It would, therefore, be advisable to apply
analyses to multiple pathway databases to verify the ro-
bustness of the results. Specifically, to accommodate path-
way enrichment analyses, we provide two additional
tables, accessible via the programmatic interfaces only. In
these tables the metabolites and genes of each pathway
database are linked to the corresponding pathways. The
results of our reaction comparison could be used to zoom
into the outcomes of an enrichment analysis to see if the
differences found can perhaps be attributed to the differ-
ent pathway definitions used by the databases.
Another additional feature offered is the possibility to
look up the fate of a metabolite, contained in any of the
five databases, by retrieving the list of reactions in whichnine + H2O→ ornithine + urea’
EC number Gene Pathway
3.5.3.1 ARG1 Urea cycle / amino group metabolism
3.5.3.1 ARG2 Urea cycle / amino group metabolism
3.5.3.1 ARG1 Urea Cycle
3.5.3.1 ARG2 Urea Cycle
ce between the reactions is the use of ornithine versus l-ornithine (both in
erlap. ‘[c]’ stands for cytosol and ‘[m]’ for mitochondrion.
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tabases in which the metabolite is a ‘dead-end’, i.e., it is
either only produced or consumed, are explicitly indi-
cated. The list of reactions provided allows the user to
find candidate reactions to resolve these dead-ends in
the network of a particular database using information
from other databases. All reactions in this list are linked
to their corresponding C2Card.
C2Cards case studies For each of the three perspectives
we provide a concrete example derived from C2Cards
Human
of consensus and conflicts between the five human path-
way databases below. The examples have all been chosen
from primary metabolic processes, highlighting that con-
flicts still occur even in well-studied parts of the metabolic
network. Moreover, we focused on examples of differences
between databases that are not easily resolved and could
point either to conflicting information or to complemen-
tary information. The case studies illustrate why manual
curation remains crucial to resolve contradicting informa-
tion and to determine in which cases further biochemical
experiments are even required to verify what is correct and
what is not.
Case study I: gene perspective
The C2Card focused on the CTPS gene (Figure 1) shows
that the gene is found in all five databases and is linked
to the same EC number by each database. However, to
which reaction(s) the databases link the gene differs.
EHMN and KEGG both link the gene to two reactions,
i.e., a glutamine dependent reaction
l−glutamineþ ATP þ UTP þ H2O → l−glutamate
þ ADP þ CTP þ orthophosphate
and an ammonium dependent reaction
ammoniumþ ATP þ UTP → ADP þ CTP
þ phosphateþ Hþ:
Reactome and HumanCyc only link the gene to the
glutamine dependent reaction and Recon 1 only to the
ammonium dependent reaction. The C2Card focused on
the glutamine dependent reaction of Reactome (Figure 1)
shows that Recon 1 does contain this reaction, but links
it only to the CTPS2 gene and not to CTPS. The same
observation can be made when starting from the EC
number perspective, as both genes are linked to the
same EC number (not shown).
The products of both the CTPS and CTPS2 gene con-
tain a glutamine amidotransferase domain and have high
sequence similarity. This and the fact that both gene
products have the same EC number suggests that they
have similar catalytic activity. For L. lactis it is known
that both ammonium derived from the hydrolysis ofglutamine by the CTP synthase enzymes themselves and
ammonium from other external sources of amine donors
can be utilized for CTP synthesis [19]. The human coun-
terparts of these enzymes may follow the same reaction
mechanism as found for L. lactis. This is supported by
the fact that under room temperature glutamine is un-
stable and will dissociate into an ammonium ion and
oxo-proline. One could, therefore, hypothesize that
CTPS and CTSP2 should be linked to both reactions for
H. sapiens as well. The glutamine and ammonium
dependent activity of CTPS2 have indeed recently been
shown in human embryonic kidney cells [20]. This
means that Recon 1 could be improved by linking the
glutamine dependent reaction to CTPS and the ammo-
nium dependent reaction to CTPS2. In Reactome and
HumanCyc the ammonium dependent reaction then
needs to be added to both genes. In this case study a
possible source of confusion for database curators might
have been the description given by NC-IUBMB for the
EC number (EC:6.3.4.2) assigned to the two gene prod-
ucts. The reaction linked to the EC number is
ATP þ UTP þ NH3 ¼ ADP þ phosphateþ CTP
and in the comments field it is stated that “Glutamine
can replace NH3”. This might explain the inconsistencies
at the reaction level to some extent.Case study II: EC number perspective
The EC number 6.2.1.4 (succinate-CoA ligase (GDP-
forming)) is found in all five databases. They all agree on
one reaction and two genes linked to it (Figure 4, reac-
tion indicated in grey). The reaction is considered to be
part of the tricarboxylic acid (TCA) cycle, a mitochon-
drial pathway, by all databases except HumanCyc. Both
EHMN and KEGG also include a very similar reaction
(Figure 4, reaction indicated in red), which only differs
with respect to its co-substrates, i.e., IDP/ITP instead of
GDP/GTP. Although IDP is a substrate for this enzyme
in vitro, it is extremely unlikely to play a role in vivo.
The concentrations of IDP and ITP are very low as com-
pared to other nucleotides due to the activity of ITPase.
Even if there is a mutation in the ITPA gene, the residual
activity of ITPase is still considerable and the IDP/ITP
concentrations remain undetectable [21]. Concluding,
the reaction with IDP/ITP as co-substrates should not
be included in the description of the human metabolic
network. Note that also in this case study the description
given by NC-IUBMB for this EC number may have been
a source of confusion. In the comments field it is stated
that ITP can act instead of GTP, which may be true for
other organisms, but not for H. sapiens.
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All five databases contain the reaction
deoxyuridineþ phosphate <¼¼>
2−deoxy−d−ribose1−phosphateþ uracil
and assigned it to similarly named pathways (Table 3).
However, there is little agreement on the EC number.
Only the one chosen by HumanCyc fits this reaction,
however in this database no gene is linked to the reac-
tion. There is no consensus between the databases re-
garding the genes. For UPP2 there is clear experimental
evidence that its gene product catalyzes the reaction
[22]. The activity of the enzymes encoded by UPP1 and
TYMP has been evaluated in human liver and placenta
[23]. The product of UPP1 showed some activity to-
wards catalyzing this reaction in placenta. However, no
activity was measured in liver, where the enzyme fulfills
its main function, the phosphorylation of uridine. The
product of TYMP mainly functions as a thymidine phos-
phorylase. Activity has been measured for catalyzing theFigure 4 Excerpt of the C2Card centered at the EC number ‘6.2.1.4’ (s
all databases, the reaction in red only in EHMN and KEGG. ‘|==|’ indicates n
symbols, retrieved via Entrez Gene IDs. Genes, the products of which form
Boolean operator ‘and' (see Materials and methods). If gene products are isdeoxyuridine reaction in liver and to a lesser extent in
placenta. For PNP there is not enough evidence clearly
confirming or refuting that its product can catalyze this
specific reaction. Additional experiments are required to
determine whether the products of this gene can
catalyze this reaction. This also illustrates that even
though the majority of the databases links PNP to the
reaction, this is not necessarily corroborated by conclu-
sive evidence. We can conclude that EHMN, HumanCyc
and KEGG should at least link the UPP2 gene to this
reaction. This would resolve the ‘missing gene’ issue in
HumanCyc. Furthermore, TYMP may need to be added
to Recon 1 and HumanCyc. Also UPP1 might need to be
added to Recon 1, HumanCyc and KEGG. Note also that
the majority of the databases does not link UPP2 to this
reaction, although clear evidence for its is available.
Discussion
We proposed the concept of Consensus and Conflict
Cards to provide concise overviews of the knowledge
contained in metabolic pathway databases for anuccinate-CoA ligase (GDP-forming)). The reaction in grey is found in
o direction provided by the database. Genes are represented by HGNC
a complex, are placed between parentheses and connected by the
ozymes ‘or’ is used.
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example, a gene of interest and see if the databases agree
on the role of its product in the metabolic network. The
C2Cards will increase the awareness of the differences
that exist between the various pathway databases. Other
initiatives also provide a web-based interface to browse
and search multiple pathway databases [24,25]. However,
they are focused on the union of various (pathway) data-
bases instead of explicitly pointing out the differences
between pathway databases. Furthermore, they do not
provide a clear and compact overview of the content of
each of the five selected databases as a C2Card does.
Also, the C2Cards application enables users to find reac-
tions that are similar to the reaction of interest, but that
are not exactly the same. The three perspectives offered
by the C2Cards application provide complementary
views on the knowledge contained in the pathway data-
bases. This makes it possible to distinguish differences
that reflect a disagreement on the underlying biology
(case studies I-III) from differences that may be
explained by, for example, different decisions taken on
how to represent knowledge (Table 2).
Ultimately, to reconcile differences and to integrate
the networks manual curation is required. While a
C2Card can highlight differences between databases, it
cannot distinguish between errors in one (or more) of
the databases and cases where databases do not agree
due to lack of consensus in the scientific literature.
Moreover, for any given organism metabolic pathway da-
tabases are still being refined, expanded, and corrected.
This makes it challenging to distinguish complementaryTable 3 Excerpt of the C2Card centered at the reaction
‘deoxyuridine + phosphate < == > 2-deoxy-d-ribose 1-
phosphate + uracil’
Database EC
number
Gene(s) Pathway
EHMN 2.4.2.1,
2.4.2.4
PNP*,
TYMP*,
UPP1
Pyrimidine metabolism
H. sapiens
Recon 1
— PNP* or
UPP2
Nucleotides
HumanCyc 2.4.2.23 — —
— — salvage pathways
of pyrimidine
deoxyribonucleotides
KEGG 2.4.2.1 PNP*
Pyrimidine metabolism
2.4.2.4 TYMP*
Reactome 2.4.2.3 UPP1 or
UPP2
Pyrimidine catabolism and
Pyrimidine salvage reactions
2.4.2.- TYMP*
Genes are represented by the HGNC symbol to which their Entrez Gene IDs
are linked. The genes on which the majority of the five pathway databases
agree, i.e., PNP and TYMP, are indicated with a ‘*’.information from cases in which the database curators
purposely excluded, for example, a reaction or gene.
Even the parts the pathway databases agree on may need
to be reviewed as the databases share information
sources and may copy data from each other, thereby
possibly propagating incorrect information. Manual cur-
ation is also needed to unambiguously assign identifiers
to genes and metabolites.
In summary, C2Cards offer an elegant solution to
bring cases that deserve further inspection to the atten-
tion of pathway database curators. The overviews may
also point out controversial biological knowledge that
should be subject of further research.
Conclusions
A biologically accurate and complete description of the
metabolic network for human and other organisms is of
utmost importance to, e.g., increase our knowledge about
pathways perturbed by a disease, find new drug targets,
and interpret the deluge of high-throughput data. A crucial
step towards a more complete description is to combine
the knowledge captured by each of the available pathway
databases for a specific organism. Much time and effort
has already been put into pathway databases and we should
profit from this to the fullest extent. However, it requires
the commitment and the support of a broad community to
construct an initial consensus network and to extend it
with new knowledge from domain experts, the scientific
literature, and as captured by the various pathway data-
bases. C2Cards can contribute to such an endeavor in sev-
eral ways. As illustrated by the three case studies the
C2Cards are a perfect starting point for further manual
curation of the human metabolic network in future recon-
struction jamborees [6]. Our application could be extended
in several ways. For example, to support reconstruction ef-
forts, we could indicate whether a reaction is balanced or
not, in addition to the already available tool to look up
dead-end metabolites. Another possible extension is to fur-
ther expand the set of five pathway databases currently
contained in C2Cards
Human with additional pathway data-
bases. Importantly, the C2Cards application can be set up
for other organisms as well (see http://www.molgenis.org/
c2cards for a description). Extending each of the three per-
spectives offered by the C2Cards
Human to multiple organ-
isms could enable using knowledge about metabolism in
model organisms to resolve conflicts between the human
pathway databases. Note that this does require the use of
an ortholog mapping such as InParanoid [26].
As a guide for integrating pathway databases, we pro-
vide overviews of which genes, EC numbers, and reac-
tions can be found in which database. The entries in
these overviews are linked to the corresponding C2Card.
One could start by curating the reactions contained in
all or the majority of the databases. In fact, for more
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bolic pathway databases, there is no agreement on the
EC numbers and genes linked to a reaction [4] and add-
itional curation is needed. C2Cards can also be of use if
a consensus network for a given organism has already
been established. We envision that the C2Cards applica-
tion could serve as a central platform in which the
consensus network can be further refined and extended
with knowledge available in pathway databases not used
for its construction. We are planning to expand
C2Cards
Human with the community-driven consensus hu-
man metabolic network Recon 2 [27], which was pub-
lished while this article was under review. By including
Recon 2 as a point of reference, we can compare this
state-of-the-art consensus network with other pathway
databases. The overview of all reactions in C2Cards
Human,
for example, could be a source of candidates for
expanding Recon 2. Bringing the differences between the
consensus network and other descriptions to the attention
of experts would enable further refinement of Recon 2. As
a first step towards such a platform, users can already add
comments to a C2Card, preferably substantiated by refer-
ences to the literature. They can subscribe to C2Cards of
their interest and receive an e-mail when new comments
are added. Different or even contradictory views possibly
held by contributors can be clearly exposed in this forum
set-up. Based on these contributions a team of curators
could then decide to incorporate the necessary changes in
the consensus network, if enough evidence supports this
claim. In the future we could extend the forum by
allowing people to rank the contributions to bring to the
foreground the forum entries deemed most important and
thereby aiding the curators. Notably, as illustrated by case
study III, it may lead to the conclusion that further bio-
chemical characterization experiments are required. Since
pathway databases are continuously being refined and
new information is being added, we could also include the
possibility to automatically alert the curators by mailing
them updated or additional C2Cards.
It is important to actively involve domain experts in
this continuous curation process, even though they may
only indirectly benefit from contributing to such an effort.
To make the barrier to contribute as low as possible, the
web interface of the C2Cards was designed to be easy to
use and suitable for users with different backgrounds. The
application can be accessed via smartphones and tablets as
well, allowing C2Cards to be viewed and discussed nearly
anywhere. Furthermore, a C2Card can be downloaded for
off-line use. The curation of a C2Card is done at the level
of a single reaction or the metabolic functions of a single
gene product. This may lower the threshold for experts to
contribute as well and also allows (very) detailed know-
ledge of just a single step in the metabolic network to be
added. One way to stimulate expert contributions wouldbe to make the contribution traceable and citable in the
form of ‘nanopublications’ [28]. A nanopublication consists
of three parts: a statement, e.g., protein X (subject) cata-
lyzes (predicate) reaction Y (object), conditions under
which the statement holds, e.g., a specific compartment,
and provenance of the statement, e.g., author and literature.
Besides that this provides an incentive for experts to share
their knowledge, it is also a way to ensure that contribu-
tions of curators are substantiated by references to the lit-
erature. We also plan to include in C2Cards
Human the
human metabolic pathways of WikiPathways [29], an open
platform in which anyone can contribute a pathway. By
incorporating the knowledge from this database we in-
directly have a second way in which experts can con-
tribute their knowledge. Ultimately, to reconstruct a
biochemical network that closely resembles the metab-
olism of a target organism, extensive literature research
and additional biochemical experiments will be needed
to resolve all conflicts revealed and to fill in the gaps
that remain. The continuous support, time and effort of
a large and diverse community are therefore essential.
C2Cards can contribute to this endeavor by simplifying
the identification of consensus and conflicts between
pathway databases and lowering the threshold for ex-
perts to contribute.
Materials and methods
Materials
C2Cards
Human was built upon the same dataset we used
previously [4] for a comparison of five pathway data-
bases, i.e., EHMN, H. sapiens Recon 1, HumanCyc, and
the human metabolic subsets of KEGG and Reactome
(Table 4). For each reaction we retrieved: the EC num-
ber(s) and gene(s) linked to it, and the pathway(s) the re-
action is part of (Table 5). To compare the reactions, we
retrieved for each metabolite, besides its primary name
and available synonyms, the chemical formula and the
following five types of metabolite identifiers, if available
in the specific pathway database: KEGG Compound,
KEGG Glycan, PubChem, ChEBI and CAS. There are
two types of PubChem IDs, Substance and Compound.
Substance IDs are specific for the depositor of the me-
tabolite. Compound IDs unite the different Substance
IDs for the same metabolite. We used the CID-SID file
(ftp://ftp.ncbi.nih.gov/pubchem/Compound/Extras/CID-
SID.gz) to convert PubChem Substance IDs to PubChem
Compound IDs.
Although not used for comparing metabolites, we also
retrieved the InChI and SMILES of metabolites, when
provided by the pathway database, as additional infor-
mation. For the genes we retrieved the Entrez Gene
and Ensembl Gene ID, if available. For display and
comparison purposes we mapped the Entrez Gene and
Ensembl Gene IDs to their corresponding HGNC
Table 4 Overview of metabolic pathway databases used
Database Export formats used Version Downloaded from
EHMN Excel 2 http://www.ehmn.bioinformatics.ed.ac.uk/
H. sapiens Recon 1 Flat file, SBML 1 http://bigg.ucsd.edu/
HumanCyc Flat file 15.0 http://biocyc.org/download.shtml
KEGG Flat file, KGML 58 http://www.kegg.jp/kegg/download/
Reactome MySQL database 36 http://reactome.org/download/index.html
All data from the pathway databases was downloaded in the first week of May 2011.
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database, respectively. Both the Entrez Gene ID and
the Ensembl Gene ID were not available for 396 genes
in HumanCyc. For 106 of these genes the UniProt ID
was used to retrieve the Entrez Gene ID and/or
Ensembl Gene ID. All out-of-date identifiers and EC
numbers were transferred to the current ID/EC num-
ber (Additional file 2). If that was not possible the ID
or EC number was flagged as being obsolete. All data
is made available under the original license terms of
the primary databases.Methods
Data retrieval and storage
We used dedicated in-house scripts to retrieve the data
needed for C2Cards
Human from the five pathway data-
bases and stored these data in a local MySQL database.
The database was designed for easy comparison of the
genes, EC numbers, and reactions. A second database,
optimized for the queries needed for generating the
C2Cards
Human (Additional file 3), was derived from this
database. To avoid heavy computations in the web appli-
cation the second database contains all pairwise matches
on gene and metabolite level and the percentage of over-
lap between every possible pair of reactions. Note that
the C2Cards themselves are composed on the fly for a
given user query.Table 5 Pathway database content statistics
Database Number of
Genes EC numbers Reactions Pathways
EHMN 2517 981 3893 69
H. sapiens Recon 1 1496 647 2617 96
HumanCyc 3586 1249 1785 257
KEGG 1535 760 1635 84
Reactome 1159 375 1175 171
Genes: counts are based on the internal database identifiers and include
genes encoding for a component of a protein complex as separate entities. EC
numbers: including incomplete EC numbers. Reactions: if reactions only differ
in direction and/or compartments they are counted as one. Pathways: counts
for HumanCyc and Reactome are based on the lowest level of their
pathway hierarchy.Matching
In C2cards
Human genes, EC numbers, metabolites and re-
actions were matched as follows:
Genes Two genes were considered to match if they
agreed based on the Entrez Gene ID and/or Ensembl
Gene ID. In addition, both types of gene identifiers
were mapped to the corresponding HGNC symbols.
This provides a basis for matching genes that are not
linked to the same genome database, i.e., Entrez Gene
or Ensembl, via their HGNC symbol. Moreover, we
computed the transitive closure of the gene matches.
This means that if for a particular gene there was a
match between database A and B, e.g., on Entrez Gene
ID, and between database B and C on, e.g., Ensembl
Gene ID then the gene was considered to match
between database A and C as well.
EC numbersMatching of EC numbers is straightforward
except for 71 incomplete EC numbers the five databases
have in total. Up to three numbers of the four that make
up a complete EC number may be missing. This is
indicated by ‘-’, e.g., EC 1.-.-.-. Incomplete EC numbers
have an ambiguous meaning [30]. They may indicate that
further specification of the enzyme activity is not
possible, but also that a complete EC number for the
specific enzyme activity is not yet included by NC-
IUBMB. To reduce the number of spurious matches,
incomplete EC numbers were matched literally, i.e., the ‘-’
was not treated as a wildcard.
Metabolites Metabolites were matched based on the
KEGG Compound ID, when available. If the KEGG
Compound ID was not provided, the metabolites had
to match on any of four other identifiers (KEGG
Glycan, ChEBI, PubChem Compound or CAS ID) or
on name. In the latter case we also required the
chemical formula to match. A difference in the number
of H atoms when comparing chemical formulae was
ignored. Furthermore, matching on names was case-
insensitive and spaces and punctuation were ignored.
Also for the metabolite matching we computed the
transitive closure (see above).
Reactions For reactions we determined the percentage of
metabolites they agreed upon, respecting the two sides of
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did not consider e-, H+, H2O in matching reactions as
with respect to these particular metabolites reactions are
not always balanced. In addition, due to the different pH
levels under which the reactions are stated in the
databases, the e- and H+ metabolites may or may not be
included in a reaction. Furthermore, we did not take into
account the compartmentalization of reactions. The
similarity of two reactions was measured by the
percentage of overlap:
matchingmetabolitesj j
max metabolitesR1j j; metabolitesR2j jð Þ  100%
where R1 and R2 denote the two reactions being
compared. Furthermore, we computed the transitive
closure for the reaction matches as well (see above).
It depends on the organism and the specific pathway
databases included in the C2Cards database which IDs
can best be used for comparing genes and metabolites.
Only a few changes to the code and the original C2Cards
database scheme are required to use other IDs for
matching. A more detailed description of the changes to
make is available on our website (http://www.molgenis.
org/c2cards).Construction web application
C2Cards
Human was built using the Molecular Genetics
Information Systems (MOLGENIS) toolkit [31]. This
software enables bioinformaticians to model a complete
web application having rich data structure and user in-
terfaces using a simple and short XML file. From this
model, the toolkit automatically generates software in
the Java language that provides a basic web user inter-
face (using Freemarker templates, http://www.
freemarker.org), and programming interfaces in Java, R,
SOAP and REST to the underlying MySQL database.
Building on these generated software we used
MOLGENIS ‘plug-in’ framework to program in Java and
JavaScript extra features that are specific for
C2Cards
Human, such as the various search options. The
result is installed on a standard Tomcat web server, but
can also run ‘standalone’ using the MOLGENIS embed-
ded web server. A local installation of C2Cards
Human is
also available upon request. All code and the database
scheme is open source and can be used as a basis for
building a C2Cards application for other organisms. A
manual on how to do this is available on our website
(http://www.molgenis.org/c2cards). The code for the
C2Cards application is available at http://www.molgenis.
org/svn/c2cards/trunk/. A copy of the core MOLGENIS
project is also required, which is available at http://www.
molgenis.org/svn/molgenis/branches/molgenis_c2cards.Representation
Each row in a C2Card contains a reaction, the EC num-
ber(s), gene(s), and the pathway linked to the reaction,
and the name of the source database. If a reaction was
assigned to multiple pathways, a separate row is used for
each pathway. The metabolites of a reaction are repre-
sented by their primary name as indicated by the path-
way database. Although not taken into account when
matching reactions, the direction of a reaction and the
compartment(s) as indicated by the source database are
shown in a C2Card. If the direction was not provided
this is indicated with ‘|==|’. Multiple EC numbers are
connected by a comma. Following the convention used
in Recon 1, genes of which the products are isozymes
are connected by the Boolean operator ‘or’. If the gene
products form a complex ‘and’ is used. EHMN and
KEGG, however, do not have a syntactic mechanism for
describing isozymes nor complexes. Therefore, if mul-
tiple genes were linked to a reaction by EHMN and
KEGG, they are connected by a comma. Genes are rep-
resented by the HGNC symbol retrieved from Entrez
Gene. The Entrez Gene ID was, however, not always
available for every gene, and the HGNC symbol could
not always be retrieved when the Entrez Gene ID was
available. In these cases we used, when available, the
Ensembl Gene ID to retrieve the HGNC symbol. For
358 genes the HGNC symbol was not available via either
gene identifier type. In this case the gene is represented
by its Entrez Gene or Ensembl Gene ID, depending on
which of these two was available. For 274 genes in
HumanCyc these two gene identifiers were also not
available and for these cases the internal gene identifier
of HumanCyc is used for representation. If multiple
HGNC symbols were linked to a gene they are separated
by two underscores. Note also that HumanCyc and
Reactome may link multiple Entrez Gene IDs to a single
gene, which in most cases will also result in multiple
HGNC symbols. Similarly, KEGG and Reactome contain
genes linked to multiple Ensembl Gene IDs.
Additional files
Additional file 1: Example of a C2Card. A C2Card centered at an EC
number may reveal possible alternative substrates, which is one of the
sources of conflict between metabolic pathway databases (Stobbe et al., BMC
Syst. Biol., 5:165, 2011). The C2Card centered at the EC number 1.1.1.35 (3-
hydroxyacyl-CoA dehydrogenase) provides an example of this scenario. The
C2Card was exported to an Excel file via the web application. This file
contains, besides the core table of the C2Card, also the overview of the
reaction comparison, and information on the metabolites, gene(s), and EC
number(s) in the C2Card. The number of unique reactions, not taking into
account compartmentalization, linked to the EC number 1.1.1.35 varies from 2
in HumanCyc and Recon 1 to 62 in EHMN, as shown in the first worksheet.
Additional file 2: Transferred and obsolete identifiers and EC
numbers per database. Number of transferred and obsolete EC
numbers, gene, and metabolite identifiers for each of the five pathway
databases.
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http://www.biomedcentral.com/1752-0509/7/50Additional file 3: Database scheme C2Cards
Human. Overview of the
tables in the database of C2Cards
Human. Only the three ‘forum_topic’
tables, the overview tables, and the table with the statistics of the
comparison of the five human pathway databases are specific for
C2Cards
Human. The SQL script needed to generate the database is
available at: http://www.molgenis.org/svn/c2cards/trunk/data/
c2cardsdb_empty.sql.
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